Jurate Asmundsson

Jurate Asmundsson

Auto-generated profile, based on publicly available information

Jurate Asmundsson

Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2026 in Acta Oncologica
Verified
Journal Article
Open access
HHHronn Hardardottir
Hronn Hardardottir
TAThor Aspelund
Thor Aspelund
BVBryndis Valdimarsdottir
Bryndis Valdimarsdottir
JAJurate Asmundsson
Jurate Asmundsson
VPVigdis Petursdottir
Vigdis Petursdottir
UVUnnur A. Valdimarsdottir
Unnur A. Valdimarsdottir

19 September 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
ADAnna Djos
Anna Djos
DTDiana Treis
Diana Treis
SFSusanne Fransson
Susanne Fransson
LMLena Gordon Murkes
Lena Gordon Murkes
SWSandra Wessman
Sandra Wessman
TMTommy Martinsson
Tommy Martinsson
A preterm infant with central hypoventilation was diagnosed with multifocal neuroblastoma. Congenital anomalies of the autonomic nervous system in association with neuroblastoma are commonly associated with germline mutations in PHOX2B. Further, the ALK gene is frequently mutated in both familial and sporadic neuroblastoma. Sanger sequencing of ALK and PHOX2B, SNP microarray of three tumor samples and whole genome sequencing of tumor and blood were performed. Genetic testing revealed a germline ALK F1174I mutation that was present in all tumor samples as well as in normal tissue samples from the patient. Neither of the patient’s parents presented the ALK variant. Array profiling of the three tumor samples showed that two of them had only numerical aberrations, whereas one sample displayed segmental alterations, including a gain at chromosome 2p, resulting in two copies of the ALK-mutated allele. Whole genome sequencing confirmed the presence of the ALK variant and did not detect any aberrations in the coding or promotor region of PHOX2B. This study is to our knowledge the first to report a de novoALK F1174I germline mutation. This may not only predispose to congenital multifocal neuroblastoma but may also contribute to the respiratory dysfunction seen in this patient.